The Watch in the Sand: Part 5
February 27, 2024
Due to overwhelming medical and economic concerns, two lobbies form a joint petition to Congress, demanding extensive regulation of Nanocule Inc, and the creation and marketing of IANs.
The Medical Practitioners Lobby cites the current high cost and scarcity of medical grade IANs as being prohibitive for family practitioners. The Pharmaceutical Lobby claims that in the future, no drug company will be able to compete with the incredibly cheap and prolific IANs using conventional drug manufacturing methods. Both lobbies claim Nanocule Inc. must be considered a monopoly, and therefore dismantled. The irony does not go unnoticed in the media.